[A15-14] Ledipasvir/sofosbuvir (Addendum to Commission A14-44)
Last updated 21.05.2015
Project no.:
A15-14
Commission:
Commission awarded on 09.04.2015 by the Federal Joint Committee (G-BA).
Report type:
Addendum
Status:
Commission completed
Department/Division:
Drug Assessment
Application field:
Immune system and infections
Note:
If the need for additional work on a project commissioned by the G-BA arises during consultations, then IQWiG presents a report in the form of an "addendum". The G-BA subsequently decides on the extent of the added benefit, thus completing the early benefit assessment.
| Project no. | Title | Status |
|---|---|---|
| A14-44 | Ledipasvir/sofosbuvir - Benefit assessment according to §35a Social Code Book V (dossier assessment) | Commission completed |
Federal Joint Committee (G-BA)
2015-05-21 A G-BA decision was published.